56919
Perfluoroperhydrophenanthrene
Selectophore™
Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
About This Item
Fórmula empírica (notación de Hill):
C14F24
Número de CAS:
Peso molecular:
624.11
Beilstein/REAXYS Number:
2514226
MDL number:
UNSPSC Code:
26111700
PubChem Substance ID:
NACRES:
NB.61
Productos recomendados
grade
for ion-selective electrodes
Quality Level
description
solvent for preparation of membranes
product line
Selectophore™
bp
212-218 °C
density
2.03 g/mL at 20 °C
SMILES string
FC1(F)C(F)(F)C(F)(F)C2(F)C(F)(C1(F)F)C(F)(F)C(F)(F)C3(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C23F
InChI
1S/C14F24/c15-1-2(16)4(18,10(29,30)14(37,38)12(33,34)6(2,21)22)8(25,26)7(23,24)3(1,17)9(27,28)13(35,36)11(31,32)5(1,19)20
InChI key
QKENRHXGDUPTEM-UHFFFAOYSA-N
Categorías relacionadas
General description
Visit our Sensor Applications portal to learn more.
Application
Perfluoroperhydrophenanthrene finds application as an intraoperative and postoperative surgical adjunct tool, during retinal operations and study.
Solvent for fluorous liquid phase in ion-selective electrodes
Legal Information
Selectophore is a trademark of Merck KGaA, Darmstadt, Germany
Storage Class
10 - Combustible liquids
wgk_germany
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Elija entre una de las versiones más recientes:
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Los clientes también vieron
I U Scott et al.
Ophthalmology, 107(5), 860-865 (2000-05-16)
To compare rates of perfluorocarbon liquid (PFCL) intraocular retention, anatomic and visual acuity outcomes, and complications associated with intraoperative perfluoro-n-octane (Perfluoron) versus perfluoroperhydrophenanthrene (Vitreon) in retinal detachment repair. Retrospective noncomparative consecutive case series. Records of consecutive patients who underwent retinal
H Wafapoor et al.
International ophthalmology, 22(2), 89-96 (1999-09-03)
To evaluate the utility and efficacy of perfluoroperhydrophenanthrene in the management of retinal detachments secondary to severe proliferative diabetic retinopathy. Forty consecutive patients with proliferative diabetic retinopathy and retinal detachments were entered into the study at nine participating clinical centers.
Ulrike Stolba et al.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 242(11), 931-936 (2004-07-20)
To evaluate the histological changes in the retina after experimental vitreous substitution with various amounts of perfluorophenanthrene (PFPH). Thirty-two rabbit eyes were mechanically vitrectomized and filled up with 0.8 cc or 0.2 cc highly purified PFPH. The substance remained for
U Stolba et al.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 237(6), 501-507 (1999-06-24)
We evaluated biomicroscopic and histological effects on the anterior segment in the rabbit eye after temporary aqueous substitution with various amounts (0.2 cc and 0.025 cc) of perfluorodecaline (PFD) and perfluorophenanthrene (PFP). A quantity of 0.2 cc of the two
The management of giant retinal tears using perfluoroperhydrophenanthrene: A multicenter Case Series
Kertes, Peter J., et al.
Ophthalmology, 104 (7), 1159-1165 (1997)
Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.
Póngase en contacto con el Servicio técnico